CLINICAL ENDOCRINOLOGY

Obesity can be associated with several endocrine alterations arising as a result of changes in the hypothalamic-pituitary hormones axes. These include hypothyroidism, Cushing’s disease, hypogonadism and growth hormone deficiency. Adipose tissue has many other important functions that can be mediated through hormones or substances synthesized and released by adipocytes which include leptin and adiponectin. Hypothyroidism is a common clinical problem seen in obese patients and could contribute to the presence of symptoms such as fatigue and inability to concentrate. Hypogonadism and growth hormone deficiencies are both associated with abdominal obesity. The treatment of these two conditions can result in improving conditioning, muscle strength, and stamina in weight loss, improved metabolic profile, and improved bone density.

 

  • Hormones as a risk factor for obesity
  • Thyroid Disorders
  • Adrenal and Pituitary Tumors
  • Obesity on Leptin

Related Conference of CLINICAL ENDOCRINOLOGY

July 09-10, 2020

5th Annual Meet on Obesity and Diet

Vienna, Austria
July 20-21, 2020

16th Euro Obesity and Endocrinology Congress

Barcelona, Spain
July 20-21, 2020

21st World Congress on Obesity and Metabolic Diseases

Manila, Philippines
July 22-23, 2020

22nd Global Obesity, Diet and Nutrition Meeting

Melbourne, Australia
October 22-23, 2020

3rd International Conference on Obesity and Diet Imbalance

Helsinki, Finland

CLINICAL ENDOCRINOLOGY Conference Speakers

Recommended Sessions

Related Journals

Are you interested in